ShadowBuys

Lobbying disclosures · Lobbying report

AMGN: third_quarter 2026 lobbying report

Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.

Follow AMGN
Became public
Oct 19, 2026, 11:23 PM EDT
Event / period date
Not stated
Collected
Nov 8, 2026, 11:40 AM EST

Why this is connected

Exact legal-name match: AMGEN INC (https://www.sec.gov/Archives/edgar/data/318154/).

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/dd128639-d8b0-4b30-abd1-c6eaaabe13af/","filing_uuid":"dd128639-d8b0-4b30-abd1-c6eaaabe13af","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/dd128639-d8b0-4b30-abd1-c6eaaabe13af/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Howard Cohen","dt_posted":"2026-10-19T23:23:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"3107 Russell Road","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22305","registrant":{"id":401027898,"url":"https://lda.gov/api/v1/registrants/401027898/","house_registrant_id":null,"name":"FEDERAL HEALTH COUNSEL, LLC","description":"Consulting and lobbying business specific to health care.","address_1":"3107 Russell Road","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22305","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HOWARD COHEN","contact_telephone":"+1 202-441-0161","dt_updated":"2026-07-21T16:49:20.791742-04:00"},"client":{"id":197129,"url":"https://lda.gov/api/v1/clients/197129/","client_id":36,"name":"AMGEN, INC.","general_description":"Pharmaceutical  Company","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-01-25"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57980,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in AMGN

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.